Stadice® (Joint Health Complex)

Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

Stadice® (Zeus Hygia) is a clinically supported joint health ingredient complex formulated to support cartilage integrity, reduce joint inflammation, and improve joint mobility and comfort. Positioned in the growing active aging and sports recovery joint health market, Stadice® combines ingredients targeting the multiple pathways of joint degradation — inflammatory cytokine signaling, cartilage matrix degradation, and synovial fluid maintenance.

Studied Dose Per Stadice® product specifications; clinical dosing per Zeus Hygia product documentation
Active Compound Proprietary joint health complex — Stadice® by Zeus Hygia; specific composition not fully disclosed; standardized botanical and structural joint support ingredients

Joint comfort and mobility support

Stadice® targets the inflammatory pathways driving joint discomfort — reducing pro-inflammatory cytokines (IL-1β, TNF-α) and COX-2 activity in synovial tissue while supporting cartilage extracellular matrix components (collagen, proteoglycans) that maintain joint structural integrity and shock absorption.

Cartilage protection and regeneration support

Joint health ingredients that combine anti-inflammatory activity with structural matrix support (collagen peptides, glucosamine, chondroitin, UC-II) address both the symptomatic and structural aspects of joint health — reducing pain while supporting the cartilage architecture that degrades with age, repeated impact, and inflammation.

Active recovery and exercise-induced joint stress

For athletes and active individuals, joint health supplementation supports faster recovery from exercise-induced joint stress, reduces post-workout joint soreness, and maintains long-term joint integrity — enabling consistent training volume without joint degradation that limits athletic longevity.

1

NF-κB inhibition and cartilage matrix support

Botanical joint health ingredients inhibit NF-κB nuclear translocation — suppressing MMP (matrix metalloproteinase) production that degrades cartilage collagen and proteoglycans, reducing IL-1β-driven chondrocyte apoptosis, and lowering COX-2/prostaglandin-mediated joint inflammation. Structural matrix ingredients simultaneously support chondrocyte anabolism and collagen synthesis to maintain cartilage extracellular matrix integrity.

1
Stadice® Joint Health — Clinical Evidence
PubMed

Clinical study data available through Zeus Hygia. Component botanical evidence supports joint health activity.

Adults with joint discomfort. Clinical assessment design.

Stadice® supplementation demonstrated improvements in joint comfort, mobility, and function markers per Zeus Hygia clinical documentation. Specific published RCT data available through NXT Ingredients platform.

Common Potential side effects

Generally well tolerated at recommended doses
Component-specific considerations apply per full formulation disclosure

Important Drug interactions

NSAIDs — some joint botanicals have COX-2 inhibitory activity; potentially additive; monitor
Anticoagulants — some joint health ingredients (omega-3, boswellia, turmeric) have mild antiplatelet activity; monitor if on blood thinners